Veracyte Inc Insider Trading
Every director, officer and 10% holder of Veracyte Inc has to report each trade in its stock within two business days of making it. This is those filings.
VCYT on carbonthat →Purchases and sales
Open-market trades only — the lines where someone chose to buy or sell at the going price.
| Insider | Action | Value |
|---|---|---|
| John LeiteGlobal Chief Commercial Off2026-09-214K shat $40.00 | Sale10b5-1 plan | $160.6K |
| Jens HolsteinDirector2026-09-145K shat $40.95 | Sale10b5-1 plan | $204.7K |
| Annie McGuireEVP, General Counsel2026-09-042.2K shat $42.79 | Sale10b5-1 plan | $92.2K |
| Annie McGuireEVP, General Counsel2026-09-041.1K shat $43.67 | Sale10b5-1 plan | $48K |
| Rebecca ChambersChief Financial Officer2026-09-042.5K shat $42.81 | Sale10b5-1 plan | $106K |
| Rebecca ChambersChief Financial Officer2026-09-041.2K shat $43.71 | Sale10b5-1 plan | $51.4K |
| Phillip G. FebboChief Scientific & Med Officer2026-09-0410.4K shat $42.89 | Sale10b5-1 plan | $446.3K |
| Phillip G. FebboChief Scientific & Med Officer2026-09-042.7K shat $43.66 | Sale10b5-1 plan | $118.1K |
| Muna BhanjiDirector2026-09-011.9K shat $42.97 | Sale10b5-1 plan | $80.1K |
Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
More on VCYT
Follow Veracyte Inc (VCYT) by email
New trades in Veracyte Inc (VCYT) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.